Conditions for diagnosis, such as a higher BMI, insulin resistance, and metabolic syndrome, patients with MAFLD having higher ALT and γ-GT, lower eGFR and significant fibrosis were excluded from the study. The gene discussed is GPT; the disease is metabolic syndrome.